Canada Pemetrexed Market Size & Outlook, 2025-2033


Canada Pemetrexed Market Insights

  • As per Reed Intelligence insights, the Canada Pemetrexed Market stood at USD 246.9 Million in 2024 and is anticipated to grow to USD 288.56 Million by 2033.
  • The Canada market is expected to advance at a CAGR of 1.72% from 2026 through 2033.
  • In 2024, Malignant Pleural Mesothelioma accounted for the highest share of the By Application market size.
  • During the forecast period, Malignant Pleural Mesothelioma is set to register the highest growth, making it the most lucrative By Application segment.

Other Key Findings


  • In 2024, Canada accounted for 10.55% of the global Pemetrexed Market size.
  • By 2033, United States is expected to lead the global Pemetrexed Market in terms of market size.
  • Within North America, United States is projected to dominate the regional Pemetrexed Market size by 2033.
  • Canada is identified as the fastest-growing market in North America, anticipated to reach USD 287.86 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 246.9 Million
Market Size In 2033 USD 288.56 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.72% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends